The pathway to prescription for sepsis patients

14 Sept 2022

This infographic describes the pathway to prescription for sepsis patients. Learn how Beckman Coulter’s MicroScan platform can be used to confirm whether an Extended Spectrum Beta-Lactamase (ESBL)-producing organism is causing the infection, enabling physicians to prescribe the most effective treatment to the patient.

Links

Tags